Quest Diagnostics Incorporated (DGX), a key player in the healthcare and biotech sector, has recently seen significant developments. The company showcased its commitment to patient-centered care with the announcement of enhanced services, increased innovation in testing, and a commitment to health equity in 2023. It formed a strategic collaboration with Sentara Health Plans to extend lab access in parts of the southeast. The company also raised guidance for full year 2024, which suggests increased optimism about its financial performance.
In recent steps towards expansion, Quest Diagnostics acquired select lab assets from both Allina Health and LifeLabs- a move expected to enhance Canadians' access to diagnostic services. For the seventh year running, the company was acknowledged as a 'Best Place to Work for Disability Inclusion'. Significant acquisitions have also been made in Ohio and University Hospitals' Lab Services.
Quest Diagnostics has a cumulative five-year gain of 62%. The company's focus on innovation, customer wins, and the release of new offerings seems to play an essential role in its noteworthy performance.
Quest Diagnostics DGX News Analytics from Mon, 08 Jan 2024 08:00:00 GMT to Sat, 05 Oct 2024 13:47:56 GMT - Innovation 8 - Rumor -2
